Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-23

Clinical Trial Update: Risk Stratification for Coronary Artery Disease With Type 2 Diabetic Patients

View source ↗

Summary

A completed clinical trial update from Acarix on risk stratification for coronary artery disease in patients with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Acarix | Conditions: Coronary Arteriosclerosis | Status: COMPLETED